EUVIMEDEUVIMED entdecken
Crossref

Cross-Cancer Type Evaluation of Potential Interstitial Lung Disease Complications of Immune Checkpoint Inhibitors Using JADER

Kazuma Koga, Yuichi Tasaka, Hideki Nawa

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b24-00130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Kazuma Koga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Clinical Pharmacy, Shujitsu University. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialImmune Checkpoint InhibitorsNeoplasmsHumansFemaleMaleCross-Sectional StudiesAgedMiddle AgedAdverse Drug Reaction Reporting SystemsJapanDatabases, FactualAntibodies, Monoclonal, HumanizedAdultAged, 80 and over

Stichwörter der Autor:innen

Japanese Adverse Drug Event Reportimmune checkpoint inhibitorinterstitial lung diseaseunderlying cancer type

Substanzen

Immune Checkpoint InhibitorsAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Graduate School of Clinical Pharmacy, Shujitsu University.
  • Department of Pharmacy, NHO Okayama Medical Center.

Zitieren

APA

Koga, K., Tasaka, Y., & Nawa, H. (2024). Cross-Cancer Type Evaluation of Potential Interstitial Lung Disease Complications of Immune Checkpoint Inhibitors Using JADER. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00130

Vancouver

Koga K, Tasaka Y, Nawa H. Cross-Cancer Type Evaluation of Potential Interstitial Lung Disease Complications of Immune Checkpoint Inhibitors Using JADER. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b24-00130

BibTeX
@article{Koga2024,
  author = {Koga, Kazuma and Tasaka, Yuichi and Nawa, Hideki},
  title = {Cross-Cancer Type Evaluation of Potential Interstitial Lung Disease Complications of Immune Checkpoint Inhibitors Using JADER},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b24-00130}
}
Kostenlos starten →